HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Petition Suggests Environmental Laws Compel FDA To Ban Oxybenzone, Octinoxate In Sunscreens

This article was originally published in The Rose Sheet

Executive Summary

Center for Biological Diversity asks FDA to ban using oxybenzone and octinoxate in sunscreens, citing their potential contribution to coral bleaching and coral death as well as potential impact on human health. If the agency does not opt to ban the ingredients, the center asks it to conduct a thorough environmental impact assessment, a measure it suggests is warranted under the National Environmental Policy Act.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121640

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel